Profile
Robert H.
Arch currently works at Immunophotonics, Inc., as President from 2025.
Dr. Arch also formerly worked at OncoSec Medical, Inc., as President, CEO & Non-Independent Director from 2022 to 2023, Elpiscience Biopharma Ltd., as Head-Research from 2019 to 2021, and China Novartis Institutes for BioMedical Research Co., Ltd., as Head-Liver Disease Department from 2017 to 2019.
Dr. Arch received his doctorate degree from Julius-Maximilians-Universität Würzburg.
Robert Arch active positions
| Companies | Position | Start |
|---|---|---|
Immunophotonics, Inc.
Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine | President | 21/09/2025 |
Former positions of Robert Arch
| Companies | Position | End |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Chief Executive Officer | 13/06/2023 |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Chief Tech/Sci/R&D Officer | 31/05/2021 |
China Novartis Institutes for BioMedical Research Co., Ltd. | Corporate Officer/Principal | 30/09/2019 |
Training of Robert Arch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
OncoSec Medical, Inc.
OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Immunophotonics, Inc.
Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine | Health Technology |
Julius-Maximilians-Universität Würzburg
Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Health Technology |
China Novartis Institutes for BioMedical Research Co., Ltd. |
- Stock Market
- Insiders
- Robert Arch
















